Abstract
Background The COVID-19 pandemic has dramatically changed medical practice worldwide. It posed a significant impact on different health services, including dermatology.
Methods A Cross-sectional observational study of 200 healthcare providers and 100 dermatologists (survey 1 and 2, respectively) were conducted.
Objectives To determine the prevalence of occupational skin diseases among healthcare providers working amid the pandemic, and to demonstrate the outbreak’s impact on dermatology practice.
Results Most healthcare providers (83%) reported hygiene-related hand dermatitis. The rates of PPE-related dermatoses were estimated to be 73%, including pressure injuries (51.9%), acne (33.1%), non-gloves contact dermatitis (29.9%), nonspecific rash (17.5%), urticaria (9.1%) and skin infections (3.2%). The emerging COVID-19-related cutaneous manifestations were recognized by 20% of surveyed dermatologists, including maculopapular rash (41.67%), urticaria (37.50%), chilblain (25%) and vasculitis (16.67). Telemedicine was provided by 73% of the dermatologists, and 89% reported minimal use of immunosuppressive drugs amid the pandemic.
Conclusions This article highlights the emergence of hygiene-related hand dermatitis and PPE-related dermatoses among healthcare providers working in the COVID-19 era. It also provides an appreciation of the major impact of COVID-19 on different aspects of dermatology practice in Iraq, and how the dermatologists adapt to these unfamiliar circumstances to meet the challenges.
Highlights
COVID-19 is associated with an ongoing emergence of occupational skin disease among healthcare providers
COVID-19 posed a significant impact on medical practice, including the epidemiology of diseases, the use of telemedicine, and modification of management plans
Dermatologists play a crucial role in recognizing the cutaneous manifestations associated with COVID-19 infection.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Non applicable
Funding Statement
Funding sources: None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Arab Board of Health Specialization, MOH Iraq
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data Availability
The used surveys are available for readers.
https://drive.google.com/drive/folders/1eH6inpIkkWpkJVmHYVNqmxXaBXQo9bJN?usp=sharing
